In transfected or endogenous RTK-expressing cells, axitinib potently blocked growth factor-stimulated phosphorylation of VEGFR-2 and VEGFR-3, thereby effectively inhibiting tumor growth, angiogenesis, and distant metastasis [27, 28]. This evidence concerns the gene KDR and neoplasm.